Biotech

Regen BioPharma Inc. Files Patent Application for Treatment of Myelodysplastic Syndrome Utilizing Gene Silencing Therapy

SAN DIEGO, CA: Company Developing Drug Candidate to Potentially Augment HemaXellerate Therapy for Treating Aplastic Anemia ...

Cellceutix to Expand Its Skin Product Pipeline

BEVERLY, MA: HDP Mimetics Active Against Bacteria Linked to Chronic Inflammatory Skin Diseases; Resistance Unlikely Compared to Other Therapies ...

Cleveland BioLabs and Incuron Announce Growth of Curaxin CBL0137 Patent Portfolio With U.S. Composition of Matter Patent

BUFFALO, NY: ...

Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM)

BERKELEY, CA: ...

Immunovaccine Disclaims Hoax Press Release

HALIFAX, NOVA SCOTIA: ...

Atossa Genetics Announces That Its Subsidiary The National Reference Laboratory for Breast Health Has Received Accreditation From the College of American Pathologists

SEATTLE, WA: ...

Horizon Pharma plc Announces Fourth Quarter and Full Year 2014 Financial Results and Raises Guidance for 2015

DUBLIN, IRELAND: Fourth Quarter Net Sales of $103.8 Million, Up 245 Percent Year over Year; Full Year Net Sales of $297.0 Million, Up 301 Percent Year over Year; Raises Net Sales and Adjusted EBITDA Guidance for 2015; ...

Henry Schein Medical to Offer Atossa Genetics'' FullCYTE Breast Aspirator

SEATTLE, WA: ...

Genetic Technologies Appoints Eutillio Buccilli as Chief Executive Officer

MELBOURNE, AUSTRALIA: ...

Arch Biopartners Announces Issuance of U.S. Patent for Peptide Solid Surface Interface

TORONTO, ONTARIO: ...